An integrated epidemiological and neural net model of the warfarin effect in managed care patients
David M Jacobs,1,2,* Filip Stefanovic,3,* Greg Wilton,2 Andres Gomez-Caminero,4 Jerome J Schentag1,2 1Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, 2CPL Associates LLC, 3Department of Biomedical Engineering, University at Buffalo School of Eng...
Guardado en:
Autores principales: | Jacobs DM, Stefanovic F, Wilton G, Gomez-Caminero A, Schentag JJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/64e9c9e3a4134706ac4afd4b46b86ef9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Sana Rashid, et al.
Publicado: (2021) -
Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?
por: Dong Lin, et al.
Publicado: (2021) -
Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation
por: Chang CC, et al.
Publicado: (2013) -
Antithrombotic Therapy in Elderly Patients with Atrial Fibrillation: The State of the Problem in the Real Clinical Practice of a Family Medicine Doctor
por: Bazira Kanat кyzy, et al.
Publicado: (2021) -
ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
por: Amer Rauf, et al.
Publicado: (2020)